OSAKA - Japanese pharmaceutical company Shionogi & Co.
OSAKA - Japanese pharmaceutical company Shionogi & Co. said Friday it aims to launch a vaccine for the novel coronavirus as early as fall next year, as it is preparing to begin clinical trials by the end of the year.
The company will advance development jointly with its subsidiary UMN Pharma Inc. and the National Institute of Infectious Diseases. Among other pharmaceutical companies, US giant Pfizer Inc. has started clinical testing of a new coronavirus vaccine and Anges Inc., a Japanese biopharmaceutical startup set up by an Osaka University professor, is currently conducting animal testing.Furthermore, Chugai Pharmabody Research Pte., a subsidiary in Singapore of Japanese drugmaker Chugai Pharmaceutical Co.
As Japan, like other countries, grapples with a rising death toll from COVID-19, the respiratory illness caused by the novel coronavirus, the government approved on Thursday the use of the anti-viral drug remdesivir in an expedited review.
Philippines Latest News, Philippines Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Japan approves remdesivir as Covid-19 treatmentTOKYO -- Japan has approved Gilead Sciences’ antiviral drug remdesivir for coronavirus treatment in a fast-track review just four days after the US...
Read more »
Japan approves experimental drug for treating coronavirus patientsJapan has approved the use of the experimental anti-viral drug remdesivir, for the treatment of coronavirus patients with severe symptoms.
Read more »
Japan approves Remdesivir for coronavirus treatmentJapan on Thursday authorized the antiviral drug remdesivir to treat coronavirus patients, the government said, with an eye to approving another medication Avigan this month.
Read more »
Japan set to approve remdesivir for coronavirus treatmentJapan plans to authorize Thursday the antiviral drug remdesivir to treat coronavirus patients, the government said, with an eye to approving another medication Avigan this month.
Read more »
Japan approves Remdesivir for coronavirus treatmentJapan on Thursday authorized the antiviral drug remdesivir to treat coronavirus patients, the government said, with an eye to approving another medication Avigan this month.
Read more »
Japan approves experimental drug for treating coronavirus patientsJapan has approved the use of the experimental anti-viral drug remdesivir, for the treatment of coronavirus patients with severe symptoms.
Read more »